HR
NTUS

Howe & Rusling’s Natus Medical Inc NTUS Stock Holding History

Howe & Rusling’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-160
Closed -$6K – 1053
2017
Q1 		$6K Hold
160
– – ﹤0.01% 640
2016
Q4 		$6K Buy
+160
New +$6.28K ﹤0.01% 647
2015
Q2 		– Sell
-1,190
Closed -$47K – 1125
2015
Q1 		$47K Sell
1,190
-155
-12% -$5.71K 0.01% 297
2014
Q4 		$48K Sell
1,345
-2,780
-67% -$93.4K 0.01% 286
2014
Q3 		$122K Buy
+4,125
New +$114K 0.03% 184
2014
Q2 		– Sell
-4,225
Closed -$109K – 947
2014
Q1 		$109K Buy
4,225
+500
+13% +$12.6K 0.03% 205
2013
Q4 		$84K Buy
3,725
+500
+16% +$9.66K 0.02% 229
2013
Q3 		$45K Buy
+3,225
New +$43.1K 0.02% 344

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Howe & Rusling's NTUS Position: Q2 2017 in Review

Howe & Rusling sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 160 shares — an estimated $6K sold.

Howe & Rusling first reported a position in NTUS in Q3 2013 and held it in 8 quarters. The position peaked at $122K in Q3 2014. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

  • Howe & Rusling reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
  • Howe & Rusling sold 160 Natus Medical Inc shares in Q2 2017, an estimated $6K.
  • Howe & Rusling first reported a position in Natus Medical Inc in Q3 2013 and held it in 8 quarters.
  • Howe & Rusling's Natus Medical Inc position peaked at $122K in Q3 2014.
  • 217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Howe & Rusling's 13F filing for Q2 2017, filed 13 Jul 2017.